Respiratory function
[대역어] 호흡기능
[용어속성] Term
[용어속성] Term
Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol
Medicine
[키워드] acute respiratory distress
administration
Adverse
ARDS
case sery
characterized
clinical condition
Clinical improvement
clinical response
clinical status
clinically
Collection
complete recovery
Course
COVID-19
COVID19
Critically ill patient
Cytokine storm syndrome
death
develop
disease
drug
Evidence
Evolution
help
Host
hyperinflammation
ICU
identify
immune-mediated diseases
Infection
inflammation response
inhibitor
JAK1
JAK2
Laboratory
mechanical ventilation
modify
Mortality
non-invasive ventilation
organ function
Oxygen requirement
pandemic
PaO
Patient
primary endpoint
progressive COVID-19
progressive disease
reduce
Research
respiratory
Respiratory distress syndrome
Respiratory function
respiratory impairment
ruxolitinib
ruxolitinib treatment
secondary endpoint
Serious Adverse Event
severe COVID-19
subsequent
subset
syndrome
the disease
therapeutic option
treat
Treatment
ventilatory support
viral-induced
was recorded
were assessed
with COVID-19
[DOI] 10.3389/fmed.2020.00466 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.00466 PMC 바로가기 [Article Type] Medicine
The safety and effectiveness of rehabilitation exercises on COVID-19 patients A protocol for systematic review and meta-analysis
6600
[키워드] Affect
change
Chinese
clinical
clinical heterogeneity
Cochrane Library
Corona
COVID-19
COVID-19 patient
COVID-19 patients
daily living
Diseases
Effect
effective
Effectiveness
Efficiency
Evidence
exclusion criteria
funnel
heterogeneity
IMPROVE
Inclusion
Infrastructure
journal
literature
Meta-analysis
outcomes
Patient
Primary outcomes
protocol
Pulmonary function
random effect model
registry
rehabilitation
rehabilitation exercises
researcher
Respiratory function
Respiratory system
retrieved
Secondary outcomes
sensitivity analysis
statistical analysis
subgroup analysis
systematic review
Web of Science
WHO
[DOI] 10.1097/MD.0000000000021373 PMC 바로가기 [Article Type] 6600
[DOI] 10.1097/MD.0000000000021373 PMC 바로가기 [Article Type] 6600
Prospects for RNAi Therapy of COVID-19
Bioengineering and Biotechnology
[키워드] acute respiratory disease
Analysis
Anti-viral drugs
approach
approaches
approved
authors
binding
caused
clinical setting
Consequences
COVID-19
develop
drug delivery
drug treatment
duplication
effective
effective intervention
emerging disease
Factor
faster
feasibility
Host
host response
immune system
Infection
limitation
lung
lung failure
lung tissue
mechanism
modulating
molecular
nucleic acid
pandemic
Perspective
pulmonary system
Region
Respiratory function
resulting
RNA
RNA interference
SARS-CoV
SARS-CoV-2
siRNA
target
targets
the SARS-CoV-2
the SARS-CoV-2 virus
Therapeutic approach
therapeutic target
Therapies
therapy
translate
urgency
Vaccine
viral entry
viral genome
viral spread
virus
[DOI] 10.3389/fbioe.2020.00916 PMC 바로가기 [Article Type] Bioengineering and Biotechnology
[DOI] 10.3389/fbioe.2020.00916 PMC 바로가기 [Article Type] Bioengineering and Biotechnology
Safety and Efficacy of Chest Physiotherapy in Patients With COVID-19: A Critical Review
Medicine
[키워드] accelerate
aerosol
Anxiety
artificial ventilation
can be used
cause
changes in
Chest
conditions
contagious
cough
COVID-19
Critical care
Cross-infection
death
Depression
diaphragmatic
diffusing
discharge
disperse
Evidence
FVC
Gas exchange
global pandemic
IMPROVE
include
Infection
limit
lung capacity
Masks
measure
morbidity
Mortality
Patient
patients with COVID-19
Physiotherapy
Pneumonia
progression
provided
Quality of life
reduce
reduction in
Respiratory failure
Respiratory function
review
Safety
Self-management
shown
Spread
surgical
Symptoms
the patient
ventilator
while
[DOI] 10.3389/fmed.2020.00454 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.00454 PMC 바로가기 [Article Type] Medicine
A Contemporary Review of Neurological Sequelae of COVID-19
Neurology
[키워드] “cytokine storm”
ACE2 receptor
addressed
Affect
Ageusia
Anosmia
approach
Brain
Cell
characterized
chemosensory
chronic neurological condition
circulation
CNS
conducted
coronavirus
COVID
COVID 19
COVID-19
COVID-19 patient
disease
dysfunction
Effect
Evidence
Follow-up
headache
immune response
Injury
manifestation
Manifestations
nervous system
nervous system function
neuroinfection
neurological
neurological sequelae
Neurological symptoms
neuronal
olfactory
Paracetamol
postmortem examination
preventive measure
progression
proportion
provided
public health crisis
public health threat
recovered patients
reported
Respiratory function
review
RNA virus
SARS-CoV-2
sensory neuron
severe cases
suggested
susceptible
Symptom
Symptoms
the disease
the SARS-CoV-2
these symptom
tissue
Treatment
vertigo
virus
while
[DOI] 10.3389/fneur.2020.00640 PMC 바로가기 [Article Type] Neurology
[DOI] 10.3389/fneur.2020.00640 PMC 바로가기 [Article Type] Neurology
Erythropoietin as candidate for supportive treatment of severe COVID-19
Review
[키워드] accumulating
affected
Brain
caused
clinical evidence
Clinical trial design
Course
COVID-19
COVID-19 patients
cytokine
Cytokine storm
double-blind
EPO
erythropoietin
Evidence
expected
Google Scholar
IMPROVE
individual
Inflammation
introduced
lung
nervous system
neuroprotection
outcome
patients
placebo-controlled
randomized clinical trial
Research
Respiratory function
SARS-CoV-2; recombinant human erythropoietin
searched
severe COVID-19
Support
Supportive treatment
therapeutic
[DOI] 10.1186/s10020-020-00186-y PMC 바로가기 [Article Type] Review
[DOI] 10.1186/s10020-020-00186-y PMC 바로가기 [Article Type] Review
Non-Overt Coagulopathy in Non-ICU Patients with Mild to Moderate COVID-19 Pneumonia
Article
[키워드] Admission
analyzed
calculated
characteristic
Chi-square
Coagulopathy
correlated
COVID-19
criteria
cut-off
cut-off value
death
diagnosed
DIC
Disseminated intravascular coagulation
distress
early stage
Hospitalized
ICU
Logistic regression analysis
material
Mild
moderate
Moderate COVID-19
Mortality
NIV
non-ICU patient
non-invasive ventilation
occurred
Occurrence
outcome
Patient
patients hospitalized
performed
Predictive
respiratory distress
Respiratory function
SARS-COV-2 infection
significantly
statistically significant
thrombotic
thrombotic complication
Thrombotic complications
value
were recorded
were used
worsening
[DOI] 10.3390/jcm9061781 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/jcm9061781 PMC 바로가기 [Article Type] Article
A Case Report of Rapidly Lethal Acute Respiratory Distress Syndrome Secondary to Coronavirus Disease 2019 Viral Pneumonia
Internal Medicine
[키워드] Acute kidney injury
acute respiratory distress
acute respiratory distress syndrome
acute respiratory syndrome
age
Berlin criteria
Brain
Case report
cerebrovascular accident
clinical status
Comorbidities
contribute
coronavirus
Coronavirus 2019
coronavirus disease (COVID-19)
COVID-19
COVID-19 patients
creatinine
death
dysfunction
end-organ
expired
female
highlight
hospital
hypertension
hypoxic
ICU
intensive care
Intubated
lethal
lethargic
pandemic
Patient
positive
Prognosis
remained
report
respiratory
Respiratory failure
Respiratory function
RNA
sarcoidosis
SARS-CoV-2
secondary to
severe ARDS
Swab test
syndrome
the patient
type 2 diabete
[DOI] 10.7759/cureus.8228 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.8228 PMC 바로가기 [Article Type] Internal Medicine
Why tocilizumab could be an effective treatment for severe COVID-19?
Commentary
[키워드] acute respiratory distress
acute respiratory distress syndrome (ARDS)
Admission
alveolar
Analysis
ARDS
Autopsy
cause
caused
contribute
COVID-19
COVID-19 patient
died
effective
Gas exchange
high mortality
Host immune response
ICU
IL-6
IL-6 pathway
IL-6 receptor
impede
Inflammatory cytokine storm
inflammatory monocyte
inflammatory storm
intensive care
monoclonal antibody
Mortality
New coronavirus
pathogenic
progressed
public health
Research
Respiratory function
returned
SARS-CoV-2
severe complication
severe COVID-19
severe COVID-19 patients
Severe patient
Spread
suggested
syndrome
T cell
target
temperature
therapeutic
Tocilizumab
Treatment
[DOI] 10.1186/s12967-020-02339-3 PMC 바로가기 [Article Type] Commentary
[DOI] 10.1186/s12967-020-02339-3 PMC 바로가기 [Article Type] Commentary